Literature DB >> 16483255

High-affinity AKAP7delta-protein kinase A interaction yields novel protein kinase A-anchoring disruptor peptides.

Christian Hundsrucker1, Gerd Krause, Michael Beyermann, Anke Prinz, Bastian Zimmermann, Oliver Diekmann, Dorothea Lorenz, Eduard Stefan, Pavel Nedvetsky, Margitta Dathe, Frank Christian, Theresa McSorley, Eberhard Krause, George McConnachie, Friedrich W Herberg, John D Scott, Walter Rosenthal, Enno Klussmann.   

Abstract

PKA (protein kinase A) is tethered to subcellular compartments by direct interaction of its regulatory subunits (RI or RII) with AKAPs (A kinase-anchoring proteins). AKAPs preferentially bind RII subunits via their RII-binding domains. RII-binding domains form structurally conserved amphipathic helices with unrelated sequences. Their binding affinities for RII subunits differ greatly within the AKAP family. Amongst the AKAPs that bind RIIalpha subunits with high affinity is AKAP7delta [AKAP18delta; K(d) (equilibrium dissociation constant) value of 31 nM]. An N-terminally truncated AKAP7delta mutant binds RIIalpha subunits with higher affinity than the full-length protein presumably due to loss of an inhibitory region [Henn, Edemir, Stefan, Wiesner, Lorenz, Theilig, Schmidtt, Vossebein, Tamma, Beyermann et al. (2004) J. Biol. Chem. 279, 26654-26665]. In the present study, we demonstrate that peptides (25 amino acid residues) derived from the RII-binding domain of AKAP7delta bind RIIalpha subunits with higher affinity (K(d)=0.4+/-0.3 nM) than either full-length or N-terminally truncated AKAP7delta, or peptides derived from other RII binding domains. The AKAP7delta-derived peptides and stearate-coupled membrane-permeable mutants effectively disrupt AKAP-RII subunit interactions in vitro and in cell-based assays. Thus they are valuable novel tools for studying anchored PKA signalling. Molecular modelling indicated that the high affinity binding of the amphipathic helix, which forms the RII-binding domain of AKAP7delta, with RII subunits involves both the hydrophobic and the hydrophilic faces of the helix. Alanine scanning (25 amino acid peptides, SPOT technology, combined with RII overlay assays) of the RII binding domain revealed that hydrophobic amino acid residues form the backbone of the interaction and that hydrogen bond- and salt-bridge-forming amino acid residues increase the affinity of the interaction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16483255      PMCID: PMC1462715          DOI: 10.1042/BJ20051970

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes.

Authors:  M G Newlon; M Roy; D Morikis; D W Carr; R Westphal; J D Scott; P A Jennings
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  A novel leucine zipper targets AKAP15 and cyclic AMP-dependent protein kinase to the C terminus of the skeletal muscle Ca2+ channel and modulates its function.

Authors:  Joanne T Hulme; Misol Ahn; Stephen D Hauschka; Todd Scheuer; William A Catterall
Journal:  J Biol Chem       Date:  2001-11-30       Impact factor: 5.157

Review 3.  The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications.

Authors:  Ronald Frank
Journal:  J Immunol Methods       Date:  2002-09-01       Impact factor: 2.303

4.  Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied endothelin B receptor.

Authors:  A Oksche; G Boese; A Horstmeyer; J Furkert; M Beyermann; M Bienert; W Rosenthal
Journal:  Mol Pharmacol       Date:  2000-06       Impact factor: 4.436

5.  Ht31: the first protein kinase A anchoring protein to integrate protein kinase A and Rho signaling.

Authors:  E Klussmann; B Edemir; B Pepperle; G Tamma; V Henn; E Klauschenz; C Hundsrucker; K Maric; W Rosenthal
Journal:  FEBS Lett       Date:  2001-11-02       Impact factor: 4.124

6.  AKAP-Lbc anchors protein kinase A and nucleates Galpha 12-selective Rho-mediated stress fiber formation.

Authors:  D Diviani; J Soderling; J D Scott
Journal:  J Biol Chem       Date:  2001-09-06       Impact factor: 5.157

7.  The molecular basis for protein kinase A anchoring revealed by solution NMR.

Authors:  M G Newlon; M Roy; D Morikis; Z E Hausken; V Coghlan; J D Scott; P A Jennings
Journal:  Nat Struct Biol       Date:  1999-03

8.  Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding.

Authors:  F W Herberg; A Maleszka; T Eide; L Vossebein; K Tasken
Journal:  J Mol Biol       Date:  2000-04-28       Impact factor: 5.469

9.  Protein kinase A anchoring proteins are required for vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells.

Authors:  E Klussmann; K Maric; B Wiesner; M Beyermann; W Rosenthal
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

10.  Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes.

Authors:  Manuela Zaccolo; Tullio Pozzan
Journal:  Science       Date:  2002-03-01       Impact factor: 47.728

View more
  27 in total

Review 1.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  The identification of novel cyclic AMP-dependent protein kinase anchoring proteins using bioinformatic filters and peptide arrays.

Authors:  William A McLaughlin; Tingjun Hou; Susan S Taylor; Wei Wang
Journal:  Protein Eng Des Sel       Date:  2010-11-29       Impact factor: 1.650

3.  Characterization of A-kinase-anchoring disruptors using a solution-based assay.

Authors:  Anne J Stokka; Frank Gesellchen; Cathrine R Carlson; John D Scott; Friedrich W Herberg; Kjetil Taskén
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

4.  Selectivity in enrichment of cAMP-dependent protein kinase regulatory subunits type I and type II and their interactors using modified cAMP affinity resins.

Authors:  Thin Thin Aye; Shabaz Mohammed; Henk W P van den Toorn; Toon A B van Veen; Marcel A G van der Heyden; Arjen Scholten; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2008-12-31       Impact factor: 5.911

Review 5.  A-kinase anchoring proteins: scaffolding proteins in the heart.

Authors:  Dario Diviani; Kimberly L Dodge-Kafka; Jinliang Li; Michael S Kapiloff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

6.  Prediction of peptides binding to the PKA RIIalpha subunit using a hierarchical strategy.

Authors:  Tingjun Hou; Youyong Li; Wei Wang
Journal:  Bioinformatics       Date:  2011-05-17       Impact factor: 6.937

7.  Cardiomyocytes from AKAP7 knockout mice respond normally to adrenergic stimulation.

Authors:  Brian W Jones; Sylvain Brunet; Merle L Gilbert; C Blake Nichols; Thomas Su; Ruth E Westenbroek; John D Scott; William A Catterall; G Stanley McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-03       Impact factor: 11.205

8.  Mechanism for targeting the A-kinase anchoring protein AKAP18δ to the membrane.

Authors:  Andreas Horner; Frank Goetz; Robert Tampé; Enno Klussmann; Peter Pohl
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

9.  Neurochondrin is an atypical RIIα-specific A-kinase anchoring protein.

Authors:  Jennifer S Hermann; Philipp Skroblin; Daniela Bertinetti; Laura E Hanold; Eva K von der Heide; Eva-Maria Wagener; Hans-Michael Zenn; Enno Klussmann; Eileen J Kennedy; Friedrich W Herberg
Journal:  Biochim Biophys Acta       Date:  2015-04-23

10.  Glycogen synthase kinase 3beta interaction protein functions as an A-kinase anchoring protein.

Authors:  Christian Hundsrucker; Philipp Skroblin; Frank Christian; Hans-Michael Zenn; Viola Popara; Mangesh Joshi; Jenny Eichhorst; Burkhard Wiesner; Friedrich W Herberg; Bernd Reif; Walter Rosenthal; Enno Klussmann
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.